[Is the FDA BLOCKING Life Saving Cancer Treatments?](https://immunitybio.com/is-the-fda-blocking-life-saving-cancer-treatments/)
Dr. Patrick Soon-Shiong has been a pioneer, leading the way in cancer research. As the Founder, Executive Chairman, Global Chief Medical & Technology Officer at ImmunityBio, Dr. Soon-Shiong is changing the paradigm in how to treat cancer. Our body needs a strong, healthy immune response to overcome cancer. Chemotherapy weakens the immune system significantly, essentially wiping out our body's best defense of cancer and tumors, the natural killer cell. The natural killer cells in our body destroy and kill cancer cells, without them, we are fighting a losing battle. Dr. Soon-Shiong's invention Anktiva, is a superagonist fusion complex that selectively activates Natural Killer (NK) cells and memory T cells enabling immune amplification rather than immune suppression. This treatment has shown long term success with over a million pages of data. This data is sitting in the hands of the FDA, but unfortunately our FDA has not reviewed it. Saudi Arabia on the other hand, has chosen longevity science and healthspan as a measure of GDP and has approved Anktiva for use in the country. This 30 minute outpatient procedure is now available in Saudi Arabia for patients dealing with cancer. Will the success of this treatment in Saudi Arabia convince the FDA to approve this treatment in America or will Americans be forced into medical tourism to treat cancer successfully and save lives?
